Home / ST14 Knockout Cell Lines

ST14 Knockout Cell Lines

Gene: ST14

Official Full Name: ST14 transmembrane serine protease matriptaseprovided by HGNC

Gene Summary: The protein encoded by this gene is an epithelial-derived, integral membrane serine protease. This protease forms a complex with the Kunitz-type serine protease inhibitor, HAI-1, and is found to be activated by sphingosine 1-phosphate. This protease has been shown to cleave and activate hepatocyte growth factor/scattering factor, and urokinase plasminogen activator, which suggest the function of this protease as an epithelial membrane activator for other proteases and latent growth factors. The expression of this protease has been associated with breast, colon, prostate, and ovarian tumors, which implicates its role in cancer invasion, and metastasis. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO35213 ST14 Knockout cell line (HCT 116) Human ST14 1:2~1:4 Negative Online Inquiry

Background

ST14 Gene Knockout Cell Lines are genetically engineered cell models specifically designed to facilitate the study of the ST14 gene, which encodes the serine protease matriptase. These cell lines enable researchers to investigate the functional consequences of ST14 gene deletion, providing insights into its role in physiological processes such as epithelial homeostasis, wound healing, and pathophysiological conditions like cancer and fibrosis.

The key function of ST14 Gene Knockout Cell Lines lies in their ability to mimic the absence of the ST14 protein, allowing scientists to analyze the cellular and molecular alterations that occur due to this genetic modification. By utilizing CRISPR/Cas9 technology, our knockout models ensure precise and efficient gene editing, which leads to a stable, reproducible cell line ideal for downstream applications. These models have proven crucial in elucidating the complex signaling pathways that matriptase regulates, facilitating a better understanding of its biological significance.

In research and clinical settings, the ST14 Gene Knockout Cell Lines serve as invaluable tools for drug discovery, target validation, and biomarker identification. They support hypothesis-driven research aimed at uncovering the intricate mechanisms underlying various diseases, which is pivotal for the development of targeted therapies and diagnostic tools.

Compared to alternative systems, our ST14 knockout models offer several advantages, including optimized performance in relevant assay conditions, high reproducibility, and the reduction of off-target effects associated with gene editing. Furthermore, these cell lines can be readily adapted for high-throughput screening, making them suitable for large-scale studies.

The value of ST14 Gene Knockout Cell Lines to researchers and clinicians cannot be overstated. They represent a powerful resource for advancing our understanding of matriptase biology and its implications in human health and disease. With our extensive expertise in the development and characterization of biological products, we are committed to providing high-quality solutions that enhance research efficiency and efficacy.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.